PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSchroder Real Regulatory News (SREI)

Share Price Information for Schroder Real (SREI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 44.90
Bid: 44.60
Ask: 45.30
Change: -0.10 (-0.22%)
Spread: 0.70 (1.57%)
Open: 44.70
High: 45.60
Low: 44.70
Prev. Close: 45.00
SREI Live PriceLast checked at -
Schroder Real Estate is an Investment Trust

To provide the shareholders with an attractive level of income, together with the potential for income and capital growth, from investing in a diversified portfolio of UK commercial real estate.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - Invista Foundation Property Trust Limited

25 Oct 2011 11:24

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Name of exempt principal trader: J.P. Morgan Securities ltd.
(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Invista Foundation Property Trust Limited

(c) Name of the party to the offer with which exempt principal trader is connected: Invista Foundation Property Trust Limited

Picton Property Income Limited

(d) Date dealing undertaken: 24 October 2011
(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer? Yes

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

(a) Purchases and sales

Class of relevant security Purchases/ sales Total number of securities Highest price per unit paid/received Lowest price per unit paid/received
Ordinary Shares Sales 10,233 0.3600 GBP 0.3600 GBP

(b) Derivatives transactions (other than options)

Class of relevant security Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities Price per unit

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercising

Class of relevant security Product description

e.g. call option

Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

The currency of all prices and other monetary amounts should be stated.

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

3. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Date of disclosure: 25 October 2011
Contact name: Andrew Mhango
Telephone number: 0207 325 4513

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

Copyright Business Wire 2011

Date   Source Headline
29th Apr 20247:00 amRNSNotice of Results
13th Mar 20244:44 pmRNSHolding(s) in Company
8th Mar 20245:01 pmRNSHolding(s) in Company
6th Mar 20245:46 pmRNSHolding(s) in Company
6th Mar 20245:42 pmRNSHolding(s) in Company
29th Feb 20242:13 pmRNSInvestor Presentation
27th Feb 20247:00 amRNSNAV and Dividend for Quarter to 31 December 2023
26th Jan 20245:02 pmRNSQuotedData's Weekly News & Interview
26th Jan 20244:23 pmRNSQuotedData's Weekly News & Interview
15th Dec 20231:03 pmRNSResult of EGM
11th Dec 202312:13 pmRNSHolding(s) in Company
21st Nov 20238:35 amRNSWebinar details
21st Nov 20237:01 amRNSDividend Announcement for the Quarter to 30 Sep 23
21st Nov 20237:00 amRNSInterim Results for the period ended 30 Sept 2023
21st Nov 20237:00 amRNSPublication of circular and notice of EGM
1st Nov 20237:00 amRNSNon-Executive Director Change
18th Oct 20234:08 pmRNSInvestor Presentation
27th Sep 20234:54 pmRNSResult of AGM
26th Sep 20234:47 pmRNSHolding(s) in Company
22nd Sep 20237:00 amRNSNotice of Results
8th Sep 202311:21 amRNSHolding(s) in Company
27th Jul 20232:43 pmRNSAnnual Report for year ended 31 March 2023
27th Jul 20232:11 pmRNSInvestor Presentation
27th Jul 20237:00 amRNSNAV and Dividend for the Quarter to 30 June 2023
8th Jun 20236:26 pmRNSDividend PID Status
8th Jun 202311:29 amRNSHolding(s) in Company
8th Jun 20237:01 amRNSDividend Declaration
8th Jun 20237:00 amRNSFull Year Results for the year ended 31 March 2023
2nd Jun 202311:18 amRNSInvestor Presentation
2nd May 20239:00 amRNSNotice of Full Year Results
20th Apr 202310:12 amRNSDirector Declaration
10th Mar 20232:12 pmRNSDirector/PDMR Shareholding
1st Mar 20234:34 pmRNSHolding(s) in Company
3rd Feb 20234:13 pmRNSInvestor Presentation
3rd Feb 20237:00 amRNSNAV and Dividend for the quarter to 30 Dec 2022
12th Dec 20227:00 amRNSKepler Trust Intelligence: New Research
1st Dec 20224:41 pmRNSHolding(s) in Company
16th Nov 20227:01 amRNSDividend Declaration
16th Nov 20227:01 amRNSDirectorate Change
16th Nov 20227:00 amRNSInterim results for the period ended 30 September
19th Oct 20227:00 amRNSInvestor Presentation
12th Oct 20227:00 amRNSNotice of Half Year Results
30th Sep 20224:53 pmRNSTotal Voting Rights
21st Sep 20224:10 pmRNSResult of AGM
15th Sep 20225:34 pmRNSTransaction in Own Shares
14th Sep 20225:18 pmRNSTransaction in Own Shares
13th Sep 20225:21 pmRNSTransaction in Own Shares
12th Sep 20225:33 pmRNSTransaction in Own Shares
9th Sep 20225:33 pmRNSTransaction in Own Shares
8th Sep 20225:29 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.